Intrinsic cellular signaling mechanisms determine the sensitivity of cancer cells to virus-induced apoptosis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wang, Yunfei ^a,b   Li, Dawei ^a,c   Luo, Jian ^a,d   Tian, Guimei ^a   Zhao, Lisa Y ^a,e   Liao, Daiqing ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b NORTHWEST A F UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR;

A-549 CELL LINE; ADENOVIRIDAE; ANIMAL; APOPTOSIS; CELL SURVIVAL; DRUG EFFECT; DRUG SCREENING; FEMALE; GENETICS; HCT 116 CELL LINE; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; NEOPLASM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; VIROLOGY;

A549 CELLS; ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; HCT116 CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE, NUDE; NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84995595336     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep37213     Document Type: Article

References (57)

1. Frisch, S. M., Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124, 619-626 (1994).
2. Grassian, A. R., Schafer, Z. T., Brugge, J. S. ErbB2 stabilizes epidermal growth factor receptor (EGFR) expression via Erk and Sprouty2 in extracellular matrix-detached cells. J Biol Chem 286, 79-90, doi: 10. 1074/jbc. M110. 169821 (2011).
3. Reginato, M. J. et al. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat Cell Biol 5, 733-740, doi: 10. 1038/ncb1026 (2003).
4. Schafer, Z. T. et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 461, 109-113, doi: 10. 1038/nature08268 (2009).
5. Paoli, P., Giannoni, E., Chiarugi, P. Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta 1833, 3481-3498, doi: 10. 1016/j. bbamcr. 2013. 06. 026 (2013).
6. Kim, Y. N., Koo, K. H., Sung, J. Y., Yun, U. J., Kim, H. Anoikis resistance: an essential prerequisite for tumor metastasis. Int J Cell Biol 2012, 306879, doi: 10. 1155/2012/306879 (2012).
7. Rytomaa, M., Lehmann, K., Downward, J. Matrix detachment induces caspase-dependent cytochrome c release from mitochondria: inhibition by PKB/Akt but not Raf signalling. Oncogene 19, 4461-4468, doi: 10. 1038/sj. onc. 1203805 (2000).
8. Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P. H., Downward, J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 16, 2783-2793, doi: 10. 1093/emboj/16. 10. 2783 (1997).
9. Tam, W. L., Weinberg, R. A. The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med 19, 1438-1449, doi: 10. 1038/nm. 3336 (2013).
10. Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10, 593-601, doi: 10. 1038/ncb1722 (2008).
11. Creighton, C. J., Gibbons, D. L., Kurie, J. M. The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective. Cancer Manag Res 5, 187-195, doi: 10. 2147/CMAR. S35171 (2013).
12. Howe, E. N., Cochrane, D. R., Richer, J. K. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res 13, R45, doi: 10. 1186/bcr2867 (2011).
13. Howe, E. N., Cochrane, D. R., Cittelly, D. M., Richer, J. K. miR-200c targets a NF-kappaB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer. PLoS ONE 7, e49987, doi: 10. 1371/journal. pone. 0049987 (2012).
14. Riaz, M. et al. miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs. Breast Cancer Res 15, R33, doi: 10. 1186/bcr3415 (2013).
15. 15., ers, C. K., Zagar, T. M., Carey, L. A. The management of early-stage and metastatic triple-negative breast cancer: a review. Hematol Oncol Clin North Am 27, 737-749, doi: 10. 1016/j. hoc. 2013. 05. 003 (2013).
16. TCGA. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70, doi: 10. 1038/nature11412 (2012).
17. Frisch, S. M. E1a induces the expression of epithelial characteristics. J Cell Biol 127, 1085-1096 (1994).
18. Grooteclaes, M. L., Frisch, S. M. Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 19, 3823-3828, doi: 10. 1038/sj. onc. 1203721 (2000).
19. Bernards, R., Schrier, P. I., Bos, J. L., Van der Eb, A. J. Role of adenovirus types 5 and 12 early region 1b tumor antigens in oncogenic transformation. Virology 127, 45-53 (1983).
20. Liu, Y., Colosimo, A. L., Yang, X. J., Liao, D. Adenovirus E1B 55-kilodalton oncoprotein inhibits p53 acetylation by PCAF. Mol Cell Biol 20, 5540-5553 (2000).
21. Frisch, S. M., Mymryk, J. S. Adenovirus-5 E1A: paradox and paradigm. Nat Rev Mol Cell Biol 3, 441-452 (2002).
22. Lipinski, K. S. et al. Differences in the interactions of oncogenic adenovirus 12 early region 1A and nononcogenic adenovirus 2 early region 1A with the cellular coactivators p300 and CBP. Virology 255, 94-105, doi: 10. 1006/viro. 1998. 9583 (1999).
23. Pelka, P., Ablack, J. N., Fonseca, G. J., Yousef, A. F., Mymryk, J. S. Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes. J Virol 82, 7252-7263 (2008).
24. Zhao, B. et al. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev 26, 54-68, doi: 10. 1101/gad. 173435. 111 (2012).
25. Moroishi, T., Hansen, C. G., Guan, K. L. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer 15, 73-79, doi: 10. 1038/nrc3876 (2015).
26. Lee, J. W., Kim, J. H. Activation of the Leukotriene B4 Receptor 2-Reactive Oxygen Species (BLT2-ROS) Cascade following Detachment Confers Anoikis Resistance in Prostate Cancer Cells. J Biol Chem 288, 30054-30063, doi: 10. 1074/jbc. M113. 481283 (2013).
27. Piccione, E. C. et al. A novel epidermal growth factor receptor variant lacking multiple domains directly activates transcription and is overexpressed in tumors. Oncogene 31, 2953-2967, doi: 10. 1038/onc. 2011. 465 (2012).
28. Frese, K. K. et al. Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein. Oncogene 22, 710-721, doi: 10. 1038/sj. onc. 1206151 (2003).
29. Thomas, M. A., Broughton, R. S., Goodrum, F. D., Ornelles, D. A. E4orf1 limits the oncolytic potential of the E1B-55K deletion mutant adenovirus. J Virol 83, 2406-2416, doi: 10. 1128/JVI. 01972-08 (2009).
30. Shea, C. et al. Adenoviral proteins mimic nutrient/growth signals to activate the mTOR pathway for viral replication. EMBO J 24, 1211-1221, doi: 10. 1038/sj. emboj. 7600597 (2005).
31. Park, S. M., Gaur, A. B., Lengyel, E., Peter, M. E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22, 894-907, doi: 10. 1101/gad. 1640608 (2008).
32. Howe, E. N., Cochrane, D. R., Richer, J. K. The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity. J Mammary Gland Biol Neoplasia 17, 65-77, doi: 10. 1007/s10911-012-9244-6 (2012).
33. Yu, Y. et al. Kindlin 2 promotes breast cancer invasion via epigenetic silencing of the microRNA200 gene family. Int J Cancer 133, 1368-1379, doi: 10. 1002/ijc. 28151 (2013).
34. Heiser, L. M. et al. Subtype and pathway specific responses to anticancer compounds in breast cancer. Proc Natl Acad Sci USA 109, 2724-2729, doi: 10. 1073/pnas. 1018854108 (2012).
35. Niepel, M. et al. Profiles of Basal and stimulated receptor signaling networks predict drug response in breast cancer lines. Sci Signal 6, ra84, doi: 10. 1126/scisignal. 2004379 (2013).
36. Kim, E. K. et al. Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis. Oncogene 30, 2954-2963, doi: 10. 1038/onc. 2011. 22 (2011).
37. Zhang, F. et al. mTOR complex component Rictor interacts with PKCzeta and regulates cancer cell metastasis. Cancer Res 70, 9360-9370, doi: 10. 1158/0008-5472. CAN-10-0207 (2010).
38. Li, H. et al. Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer. Breast Cancer Res Treat 134, 1057-1066, doi: 10. 1007/s10549-012-2036-2 (2012).
39. Gulhati, P. et al. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res 71, 3246-3256, doi: 10. 1158/0008-5472. CAN-10-4058 (2011).
40. Tanaka, K. et al. Oncogenic EGFR signaling activates an mTORC2-NF-kappaB pathway that promotes chemotherapy resistance. Cancer Discov 1, 524-538, doi: 10. 1158/2159-8290. CD-11-0124 (2011).
41. Zhao, L., Yue, P., Khuri, F. R., Sun, S. Y. mTOR complex 2 is involved in regulation of Cbl-dependent c-FLIP degradation and sensitivity of TRAIL-induced apoptosis. Cancer Res 73, 1946-1957, doi: 10. 1158/0008-5472. CAN-12-3710 (2013).
42. Park, S. I., McCauley, L. K. Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells. Endocr Relat Cancer 19, 243-254, doi: 10. 1530/ERC-11-0278 (2012).
43. Wang, H. et al. Stabilization of Snail through AKT/GSK-3beta signaling pathway is required for TNF-alpha-induced epithelialmesenchymal transition in prostate cancer PC3 cells. Eur J Pharmacol 714, 48-55, doi: 10. 1016/j. ejphar. 2013. 05. 046 (2013).
44. Chen, C. H. et al. Autoregulation of the Mechanistic Target of Rapamycin (mTOR) Complex 2 Integrity Is Controlled by an ATPdependent Mechanism. J Biol Chem 288, 27019-27030, doi: 10. 1074/jbc. M113. 498055 (2013).
45. Kumar, A. et al. Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism. Diabetes 59, 1397-1406, doi: 10. 2337/db09-1061 (2010).
46. Lamming, D. W., Sabatini, D. M. A Central Role for mTOR in Lipid Homeostasis. Cell Metab 18, 465-469, doi: 10. 1016/j. cmet. 2013. 08. 002 (2013).
47. Yuan, M., Pino, E., Wu, L., Kacergis, M., Soukas, A. A. Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2. J Biol Chem 287, 29579-29588, doi: 10. 1074/jbc. M112. 386854 (2012).
48. Hagiwara, A. et al. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab 15, 725-738, doi: 10. 1016/j. cmet. 2012. 03. 015 (2012).
49. Masui, K. et al. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. Cell Metab 18, 726-739, doi: 10. 1016/j. cmet. 2013. 09. 013 (2013).
50. TCGA. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615, doi: 10. 1038/nature10166 (2011).
51. Liu, P. et al. Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis. Nat Cell Biol 15, 1340-1350, doi: 10. 1038/ncb2860 (2013).
52. Guertin, D. A. et al. mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice. Cancer Cell 15, 148-159, doi: 10. 1016/j. ccr. 2008. 12. 017 (2009).
53. Berk, A. J. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 24, 7673-7685 (2005).
54. Pool, S. E. et al. mTOR inhibitor RAD001 promotes metastasis in a rat model of pancreatic neuroendocrine cancer. Cancer Res 73, 12-18, doi: 10. 1158/0008-5472. CAN-11-2089 (2013).
55. Li, Q. et al. Inhibition of p53 by Adenovirus Type 12 E1B-55K Deregulates Cell Cycle Control and Sensitizes Tumor Cells to Genotoxic Agents. J Virol 85, 7976-7988, doi: 10. 1128/JVI. 00492-11 (2011).
56. Yang, H. et al. Small-Molecule Inhibitors of Acetyltransferase p300 Identified by High-Throughput Screening Are Potent Anticancer Agents. Mol Cancer Ther 12, 610-620, doi: 10. 1158/1535-7163. MCT-12-0930 (2013).
57. Yang, H., Zheng, Z., Zhao, L. Y., Li, Q., Liao, D. Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection. Cell Cycle 11, 582-593, doi: 10. 4161/cc. 11. 3. 19052 (2012).